Gritstone bio, announced that the company’s Board of Directors granted two employees nonqualified stock options to purchase an aggregate of 28,000 shares of its common stock with an exercise price of $3.67, which is equal to the closing price of Gritstone’s common stock on January 9, 2023, the date of the grant. These stock options are part of an inducement material to each of the new employees becoming an employee of Gritstone, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options will vest over a four-year period, with 25% of the options vesting on the first anniversary of the employees’ date of hire, and 1/48th of the options vesting monthly thereafter, subject to the employees’ continued employment with Gritstone on such vesting dates.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on GRTS:
- Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Gritstone bio to Participate in Upcoming Investor Conferences
- Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference
- Biotech Alert: Searches spiking for these stocks today